DGY-06-116 is primarily utilized in the field of pharmaceutical research and development. It serves as a key compound in the study of potential therapeutic agents, particularly in the area of targeted drug therapies. Researchers focus on its application in inhibiting specific enzymes or receptors that are implicated in various diseases, such as cancer or inflammatory disorders. Its role in preclinical studies helps in understanding the efficacy and safety profile of new drug candidates. Additionally, DGY-06-116 is used in biochemical assays to explore molecular interactions and pathways, aiding in the discovery of novel treatment strategies. Its application extends to the optimization of drug formulations, ensuring improved bioavailability and stability of active pharmaceutical ingredients.